Filing Details
- Accession Number:
- 0001179110-17-014597
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-11-24 17:54:42
- Reporting Period:
- 2017-11-21
- Accepted Time:
- 2017-11-24 17:54:42
- Original Submission Date:
- 2017-11-22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690460 | Marion Dorsch | C/O Blueprint Medicines Corporation 38 Sidney Street, Suite 200 Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-21 | 500 | $64.44 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4/A were effected pursuant to a trading plan adopted on June 22, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This amendment is being filed solely to correct the fact that the original filing inadvertently stated that these securities were acquired, rather than disposed of.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.42 to $64.51 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges.
Billionaire Hedge Funds
